The American Medical Women Association and Phi Delta Epsilon from the University of Antigua (AUA) teamed up with Dr Lestor Simon, Chief Pathologist of the Mount St John Medical Centre and Dr. Prince Ramsey, Family Physician and HIV/AIDS Clinical Care Coordinator in Antigua and Barbuda, in conducting an HIV /AIDS Seminar at the AUA Campus at Jabberwock. The theme of the Seminar was "Stop Aids. Be Safe" and involved several key speakers and live testimonials from HIV patients.
Dona T. Hasou, SGA Executive Board
President AUA remarked, "When we, the students of AUA, heard about the
increasing incidence of HIV in Antigua, we
felt that it was important for us, as future physicians, to help in some way.
This seminar not only serves to provide information about prevention, but also
raises money for Antiguan organizations that have made the fight against the
spread of HIV/AIDS their mission."
"We can read so much about HIV in our classes but this seminar gives us the opportunity to listen to doctors that interact with HIV daily and also hear first hand testimonials of how it is affecting the lives of the people who have it." Gary Livingstone, Phi Delta Epsilon President said.
Dr. Simon explained the importance of making the transfer of
molecular nexus of the disease to what happens socially in
sexual engagement - Abstention vs. tropism. He stressed the importance of safety and testing.
Dr. Prince Ramsey welcomed the students and explained
that he has been offering voluntary counseling and treating HIV patients since
1986 when Antigua saw the first case on the
island. "There is room for the medical students to participate in the voluntary
program" he said. He explained that the problem facing us is that the patients
do not take the medication once they feel okay. This causes them to develop a
resistance to the disease to which they eventually succumb. Currently there are
164 patients in HIV care, and the disease is more prevalent in females.
Mrs. Elenor Frederick, Public Health Consultant and Researcher explained that she is currently engaged in research to be able to allow for testing the Viral loads in Antigua to more effectively track the virus, evaluate the response to therapy and monitor patients. This is critical for evaluating the response to the disease.